Researcher Profile

Kang, Minho image
Kang, Minho(강민호) 36

Personalized Genomic Medicine Research Center (유전체맞춤의료전문연구단)

Keywords Cloud

KRIBB Co-Working

Results 21-36 of 36 (Search time: 0.005 seconds).

No. Year Title Type
16 2019

2019Research Project

암 특이대사와 젖산유래 세포신호체계의 동반조절 기전분석 및 대사성 종 양 맞춤치료기술 개발연구책임자 : 염영일 / 사업기간 : 2019.04.29 ~ 2020.02.28
Research Project
15 2019

2019Article

Lactate activates the E2F pathway to promote cell motility by up-regulating microtubule modulating genesCancers, vol. 11, no. 3, pp. 274-274Yi Deun Jung; Jung Hee Cho; Seulki Park; Minho Kang; Seung Jin Park; Dong Hee Choi; Moonkyung Jeong; Kyung Chan Park; Young Il Yeom; Dong Chul Lee
Article
14 2019

2019Article

Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK/p27KIP1/pRB pathwayCancer Letters, vol. 461, pp. 78-89H J An; M Ryu; H J Jeong; Minho Kang; H M Jeon; J O Lee; Y S Kim; H Lee
Article
13 2018

2018Patent

NDRG3 발현 또는 활성 억제제를 유효성분으로 함유하는 염증질환 예방 및 치료용 약학적 조성물KR10-2014-0063002 (2014.05.26) / 10-1904343 (2018.09.27)염영일; 박경찬; 손현암; 강민호이동철
Patent
12 2018

2018Research Project

유전체 빅데이터 기반 난치성 질환 맞춤치료 원천기술 개발사업 = Genomic big-data driven study of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2018.01.01 ~ 2018.12.31
Research Project
11 2018

2018Research Project

혁신 바이오신약 개발 플랫폼 구축 = Platform development for innovative biotherapeutics연구책임자 : 이동철 / 사업기간 : 2018.01.01 ~ 2018.12.31
Research Project
10 2018

2018Research Project

암 특이대사와 젖산유래 세포신호체계의 동반조절 기전분석 및 대사성 종 양 맞춤치료기술 개발연구책임자 : 염영일 / 사업기간 : 2018.06.29 ~ 2019.04.28
Research Project
9 2018

2018Article

RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivationCell Death & Disease, vol. 9, no. 6, pp. 587-587Jung Hee Cho; Yeon Mi You; Young Il Yeom; Dong Chul LeeBo Kyung Kim; Mi Sun Won; B C Cho; Mingho Kang; Seulki Park; Suk-Jin Yang, et al.
Article
8 2017

2017Patent

NDRG3 발현 또는 활성 억제제를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물KR10-2014-0063014 (2014.05.26) / 10-1721492 (2017.03.24)염영일; 박경찬; 손현암; 강민호이동철
Patent
7 2017

2017Research Project

표현형분석 기반 고기능성 유용유전자 고속발굴시스템 구축 및 활용 = Phenotype-based high-throughput identification of biological targets with high functionality연구책임자 : 염영일 / 사업기간 : 2017.12.26 ~ 2018.12.25
Research Project
6 2017

2017Article

Regulation of hypoxia responses by flavin adenine dinucleotide-dependent modulation of HIF-1α protein stability = FAD 의존적인 HIF-1a 단백질 안정성 제어를 통한 저산소반응 조절 기전EMBO Journal, vol. 36, no. 8, pp. 1011-1028Suk Jin Yang; Young Soo Park; Jung Hee Cho; Byul Moon; Hyun Jung Ahn; J Y Lee; Z Xie; Y Wang; D Pocalyko; Dong Chul Lee, et al.
Article
5 2016

2016Patent

NDRG3 발현 또는 활성 촉진제를 유효성분으로 함유하는 허혈성 질환 예방 및 치료용 약학적 조성물KR10-2015-0053453 (2015.04.15) / 10-1663029 (2016.09.29)염영일; 박경찬; 손현암; 강민호이동철
Patent
4 2016

2016Article

High-resolution transcriptome analysis reveals neuropathic pain gene-expression signatures in spinal microglia after nerve injuryPain, vol. 157, no. 4, pp. 964-976H Jeong; Y J Na; K Lee; Y H Kim; Y Lee; Min Ho Kang; B C Jiang; Young Il Yeom; L J Wu; Y J Gao, et al.
Article
3 2015

2015Article

A lactate-induced response to hypoxia = 젖산 매개 저산소 반응Cell, vol. 161, no. 3, pp. 595-609Dong Chul Lee; Hyun Ahm Sohn; Z Y Park; Sangho Oh; Y K Kang; K M Lee; Min Ho Kang; Ye Jin Jang; Suk Jin Yang; Young Ki Hong, et al.
Article
2 2014

2014Article

Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation studyBiology of Blood and Marrow Transplantation, vol. 20, no. 5, pp. 696-704In Pyo Choi; Suk Ran Yoon; Soo Yeon Park; Hanna Kim; Sol-Ji Jung; Ye Jin Jang; Min Ho Kang; Young Il Yeom; J L Lee; D Y Kim, et al.
Article
1 2013

2013Article

Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cellsMolecules and Cells, vol. 35, no. 4, pp. 335-341Yuri Jung; Y J Jang; Min Ho Kang; Young Soo Park; Su Jin Oh; Dong Chul Lee; Z Xie; H S Yoo; Kyung Chan Park; Young Il Yeom
Article
1 2